Eurofins Scientific SEWBO:ESF +0.70%77 Interest Coverage is 4.78 as of Dec. 2025, which is 8% below its 10-year median of 5.18. GuruFocus rates WBO:ESF with a GF Score™ of 77/100 and a GF Value™ of €66.89 (Fairly Valued). The stock has 7 warning signs investors should review. Among 95 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks worse than 68.42% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Eurofins Scientific SE's
Operating Income
for the
six
months ended in Dec. 2025 was €410 Mil. Eurofins Scientific SE's Interest Expense for the
six
months ended in Dec. 2025 was €-86 Mil.
Eurofins Scientific SE's interest coverage for the quarter that ended in Dec. 2025 was 4.78.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Eurofins Scientific SE's Interest Coverage or its related term are showing as below:
WBO:ESF'
s Interest Coverage Range Over the Past 10 Years
Min: 3.3 Med: 5.18 Max: 13.42
Current: 5.21
WBO:ESF's Interest Coverage is ranked worse than 68.42% of 95
companies
in the Medical Diagnostics & Research industry
Industry Median: 9.05
vs WBO:ESF: 5.21
Eurofins Scientific SE (WBO:ESF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Eurofins Scientific SE Interest Coverage Related Terms
Eurofins Scientific SE Interest Coverage Historical Data
* Premium members only.
The historical data trend for Eurofins Scientific SE's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
WBO:ESF vs TMO, DHR, IDXX: Interest Coverage Comparison
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Interest Coverage falls into.
Eurofins Scientific SE Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE (WBO:ESF) has a Interest Coverage of 4.78 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Eurofins Scientific SE and its competitors. This is near median its historical median of 5.18. Over the past decade, Eurofins Scientific SE's Interest Coverage has ranged from 3.30 to 13.42. According to the industry distribution chart, Eurofins Scientific SE ranks #65 out of 95 companies in the Medical Diagnostics & Research industry, placing it in the top 68.4%.
Is Eurofins Scientific SE's Interest Coverage too high?
Eurofins Scientific SE's current Interest Coverage of 4.78 is near median its 10-year median of 5.18. Over the past 10 years, this metric has ranged from a low of 3.30 to a high of 13.42. The Medical Diagnostics & Research industry median Interest Coverage is 9.05. Eurofins Scientific SE's value of 4.78 is 47.2% below this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #65 out of 95 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #65 out of 95 companies for Interest Coverage. This places Eurofins Scientific SE in the lower half of its industry. The industry median Interest Coverage is 9.05. Eurofins Scientific SE's value of 4.78 is 47.2% below this benchmark. Historically, Eurofins Scientific SE's own Interest Coverage has ranged from 3.30 to 13.42 over the past decade. While the company's 10-year median is 5.18 vs. the industry median of 9.05, Eurofins Scientific SE has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.05, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current Interest Coverage of 4.78 is 47.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current Interest Coverage is 4.78, which is near median its own 10-year median of 5.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (WBO:ESF) is currently considered Fairly Valued. The stock's GF Value™ is €66.89, compared to a current price of €68.70 — trading 2.7% above its estimated fair value. The current Interest Coverage is 4.78, which is near median its 10-year median of 5.18 and 47.2% below the Medical Diagnostics & Research industry median of 9.05. Eurofins Scientific SE's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Eurofins Scientific SE (WBO:ESF), the current Interest Coverage is 4.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (WBO:ESF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of €68.70 is trading 2.7% above its estimated GF Value™ of €66.89.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for WBO:ESF:
Interest Coverage: 4.78 (near median its 10-year median of 5.18)
GF Value™: €66.89 vs. price of €68.70 (2.7% above fair value)
Industry Position: 47.2% below the Medical Diagnostics & Research median (#65 of 95)
No single metric tells the full story. See the WBO:ESF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
77GF Score
Get the complete analysis for WBO:ESF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ESF has been successfully added to your 
